High Throughput Affinity Purification of Monoclonal Antibodies

The production of recombinant proteins have made a revolutionary impact on human healthcare by enabling mass production of safe and effective therapeutic drugs such as hormones, growth factors, blood coagulation products, thrombolytic agents, vaccines, and monoclonal antibodies (mAbs).

Hamilton and PhyNexus have teamed-up to deliver an automated workflow solution which purifies up to 50 mL volumes of target antibody from transient transfection. Purifying sufficient antibody volumes for downstream applications can be a tedious and time-consuming task. Low expression efficiency of recombinant proteins from transient transfection means microscale purification must be repeated many times, in order to yield the sufficient concentrated solution of antibodies.

•  Entire purification in less than 15min
•  Very high protein yield and concentration with excellent purity
•  Flexible choice of resin bed size

Please have a look at the attached PDF for more information

Contact Hamilton at info.nordic@hamilton.ch, to receive more information and discuss your specific needs with our support team.